Focus of Pharmacologic Agents Used in Rapid Sequence Intubation (RSI)

Session Summary

Rapid sequence intubation (RSI) is a critical procedure used to quickly secure an airway in patients who are unstable and at risk for aspiration. It involves the administration of intravenous sedatives and neuromuscular blocking agents to facilitate intubation. This presentation explores commonly used agents such as etomidate, ketamine, propofol, succinylcholine and rocuronium and examine their pharmacologic profiles and hemodynamic effects following RSI. Recommendations based on the 2023 Society of Critical Care Medicine Clinical Practice Guidelines for RSI are also explored. Pharmacology content = 70%

Objectives

Describe the indications and critical techniques for rapid sequence intubation (RSI) to rapidly secure an airway.
Discuss pharmacologic profiles, mechanisms of action, hemodynamic effects of sedatives and neuromuscular blocking agents used in RSI.
Apply evidence-based recommendations from the 2023 SCCM Clinical Practice Guideline for patient safety and outcomes during peri-RSI period.

Topics Pharmacology

Population Adult

Role APRN, Staff

Call for Abstracts: Have a great idea for a session or a poster?
Click here to apply.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for 1.00 contact hours.

Disclosure

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.

Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.